VEO Ophthalmics, LLC

VEO Ophthalmics, LLC

- Medical Device

0

Managing congenital aniridia and acquired iris defects — including, but not limited to, traumatic iris defects and traumatic mydriasis — is often challenging. When iris reconstruction is necessary, the CUSTOMFLEX® ARTIFICIALIRIS is a unique device that offers both surgeons and patients important benefits.

Products Details

INDICATIONS
The CUSTOMFLEX® ARTIFICIALIRIS is intended for use as an iris prosthesis for the treatment of iris defects. The CUSTOMFLEX® ARTIFICIALIRIS is indicated for use in children and adults for the treatment of full or partial aniridia resulting from congenital aniridia, acquired defects, or other conditions associated with full or partial aniridia.

CUSTOM-COLOR MATCH
Every CUSTOMFLEX® ARTIFICIALIRIS is custom-made to match the patient's natural iris tissue, addressing both symptomatic and cosmetic aspects of iris defects.

Benefits

  • Biocompatibility: Long, safe history of highly biocompatible medical-grade silicone
  • Flexibility: Flexible material that can be folded for insertion through small incisions using forceps or an auto injector
  • Versatility:
    • Sutureless and Sutured Surgical Procedures:
      • Capsular bag placement
      • Passive sulcus fixation with or without sutures
      • Suture fixation to the scleral wall
      • PCIOL Sutured Ex vivo to the CUSTOMFLEX® ARTIFICIALIRIS
    • Can be easily sized for each patient’s needs
    • Can be implanted with most intraocular lenses
  • Limits Light Transmission: Reduces photosensitivity symptoms and can be used to treat transillumination defects with a fixed aperture of 3.35mm and opaque black posterior surface to absorb light
  • Customized: Every CUSTOMFLEX® ARTIFICIALIRIS is custom-made to match the patient’s natural iris tissue, addressing both symptomatic and cosmetic aspects of iris defects.

Specifications

  • Overall Diameter: 12.8 mm
  • Pupil Size: 3.35 mm
  • Injectable

Customflex Artificialiris Clinical Science

The safety and efficacy of the CUSTOMFLEX® ARTIFICIALIRIS was demonstrated in a non-randomized clinical trial of 447 eyes of 389 adult and pediatric patients with aniridia or other iris defects. There was an overall significant improvement in photosensitivity symptoms, quality of life, and vision in pediatric and adult subjects. At study conclusion, 63% of eyes reported no or mild daytime light sensitivity; and, 79% reported no or mild nighttime light sensitivity, while more than 70% of eyes reported no or mild glare during the day or at night. 94% of subjects were satisfied with the CUSTOMFLEX® ARTIFICIALIRIS appearance.

Customer reviews

No reviews were found for Customflex Artificialiris - Medical Device. Be the first to review!